Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients: observational cohort study using the OpenSAFELY platform
Zheng et al., medRxiv, doi:10.1101/2023.01.20.23284849
https://c19early.org/zheng5v.html